Clinical trials
Every registered trial of Liraglutide
471 studies, 25 still enrolling.
Plain-Language Summary
Plain-language reading of the public trial registries.
In short
- Liraglutide has been studied in people a great deal.
- 471 registered studies in total.
- 25 are still enrolling people, so this is active research, not just history.
What kind of research
- 419 studies actually gave the peptide to volunteers and measured what happened. This is the kind of study that can show whether something works.
- About 87,455 people took part in those.
- A further 52 studies only looked at records of people already taking it. These are counted separately because nobody was given the peptide for the study, so they cannot prove cause and effect.
How far along it is
- 224 trials have reached phase 3 or 4 — the large, late-stage trials regulators rely on to approve a drug.
- 183 have published results in the medical literature that anyone can read.
- The research spans 67 countries.
A registered trial is a plan, not a result. Registration means a study was declared in advance; it says nothing about whether the peptide worked, and a trial can be registered and then abandoned.
Filter
Showing 471 of 471 trials for Liraglutide.
Metabolic Surgery for Atrial Fibrillation Elimination
Ali Aminian
Atrial Fibrillation · Obesity and Obesity-related Medical Conditions
Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.
TP04HN106 in the Treatment of Patients With Amyotrophic Lateral Sclerosis
Talengen Institute of Life Sciences, Shenzhen, P.R. China.
Amyotrophic Lateral Sclerosis
Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.
RWS of of Liraglutide Alone and in Combination With Orlistat for Weight Loss in Overweight/Obese Patients.
The Fourth Affiliated Hospital of Zhejiang University School of Medicine
Overweight and Obese Adults
The Evira Study: Additional Support During Obesity Treatment
Karolinska Institutet
Childhood Obesity · Treatment Adherence
Estimating the Impact of Obesity Medications on Clinical and Economic Outcomes
Indiana University
Obesity
Examination of How the Duration of Fasting and Temporary Stopping of GLP-1 Medications Affect the Amount of Food Left in the Stomach in People Using Liraglutide (Injected), Semaglutide (Taken by Mouth) or Semaglutide (Injected)
Novo Nordisk A/S
Obesity
The Effect of Glycemic Control and of GLP-1 Receptor Agonism on Islet GLP-1 in People With Type 1 and Type 2 Diabetes
Mayo Clinic
Type 1 Diabetes · Type 2 Diabetes
Behavioral Therapy and GLP-1 Analogue Effects on Binge Eating, Weight, and Coping in Obesity
Haukeland University Hospital
Binge Eating Disorder Associated With Obesity · Binge Eating Disorder · Eating Disorder Binge · Eating Disorders
Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.
A Trial to Investigate the Safety and Efficacy of Intra-articular 4P004 Injection in Subjects With Knee Synovitis and Osteoarthritis
4Moving Biotech
Knee Osteoarthritis · Synovitis of Knee
Tirzepatide vs Liraglutide in Bone
National and Kapodistrian University of Athens
Obesity (Disorder)
Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.
Liraglutide Treatment in Obese Infertile PCOS Women
Peking University Third Hospital
PCOS · Obesity · Infertility
Liraglutide Treatment in Patients With Maturity-onset Diabetes of the Young (MODY)
Mansa
Maturity Onset Diabetes of the Young
Preoperative Use of Liraglutide Additionally to Common Dietological Measures as Opposed to Dietological Measures Alone
Medical University of Vienna
Obesity, Adolescent
C5541010
Pfizer Inc.
Obesity, Overweight
Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.
Efficacy and Safety of the Met+SGLT-2i+GLP-1RA in Patients With Type 2 Diabetes With Poor Glycemic Control
Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.
T2DM (Type 2 Diabetes Mellitus)
Beta Cell Function in Type 2 Diabetes: Differential Effects of SGLT2 Inhibitors and GLIP-Receptor Agonists
MaryAnn Banerji
Type 2 Diabetes (T2DM)
Liraglutide in Preventing Delirium in Diabetic Elderly After Cardiac Surgery
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Delirium, Postoperative
Investigation of the Relationship Between Peripheral and Central Metabolic Changes Induced by GLP-1 Agonists
Nils Opel
Healthy
Effect of Liraglutide in Obese Women With Polycystic Ovary Syndrome
Beni-Suef University
Polycystic Ovary
Holding vs. Continuing Incretin-based Therapies Before Upper Endoscopy
The Cleveland Clinic
Diabetes Mellitus, Type 2 · Obesity · Gastroparesis
Fibrosis Lessens After Metabolic Surgery
The Cleveland Clinic
Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD) · Non-Alcoholic Fatty Liver Disease · Metabolic Dysfunction-Associated Steatohepatitis (MASH) · Liver Fibrosis
Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.
GLP_1 RA Ultrasound Study
Children's Hospital Medical Center, Cincinnati
Glucagon Like Peptide-1 (GLP-1 · Delayed Gastric Emptying · Risk of Aspiration · Diabetes
Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.
Risk Factors Affect Weight Loss Outcomes After Treatment.
E-DA Hospital
Weight Regain
Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.
Impact of Bariatric Surgery and Liraglutide on Cognitive-Behavioral Markers of Long-Term Weight Loss in Obesity
I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio
Obesity and Overweight
Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.
Effects of Liraglutide on Body Surface Gastric Mapping
Alimetry
Gastroparesis · Functional Dyspepsia · Chronic Nausea and Vomiting Syndrome · Healthy
Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.
Phase 1 Study Assessing the Pharmacokinetics of NEX-22A in Subjects With T2D
Nanexa AB
Type 2 Diabetes
A Study Comparing Degu Insulin Liraglutide Injection With Premixed Insulin on the Prognosis of Diabetes Mellitus
Beijing Tsinghua Chang Gung Hospital
Type 2 Diabetic Patients
Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.
LIROH - Liraglutide for Obesity in HIV
Brigham and Women's Hospital
Obesity · HIV Infections
Study to Evaluate the Safety and Effectiveness of Saxenda® for Weight Management in Routine Clinical Practice in Taiwan.
Novo Nordisk A/S
Obesity
Use of Liraglutide in Children Aged 6 to 12 Years With Severe Obesity
University of Sao Paulo General Hospital
Severe Obesity · Cardiovascular Function · Liraglutide · Childhood Obesity
Study of Liraglutide (A Weight Loss Drug) in High Risk Obese Participants With Cognitive and Memory Issues
University of Chicago
Multiple Sclerosis · Long COVID · Long Covid19 · Obese
Pharmacological Treatment - An Overview of Its Role in Managing Childhood Obesity
Göteborg University
Obesity (Disorder) · Child Obesity
Liraglutide and Metformin Combination on Weight Loss, Metabolic - Endocrine Parameters and Pregnancy Rate in Women With PCOS, Obesity and Infertility
Mỹ Đức Hospital
Polycystic Ovary Syndrome · Obesity · Infertility, Female
Efficacy and Safety of Liraglutide in the Treatment of Obesity Combined With Metabolism Associated Fatty Liver Disease
Affiliated Hospital of Nantong University
Non-alcoholic Fatty Liver Disease · Obesity
Clinical, Morphometric and Biochemical Effects on Adiposopathy Associated With the Use of GLP-1RA in CKD
Cardenal Herrera University
Chronic Kidney Disease stage3 · Chronic Kidney Disease stage4 · Chronic Kidney Disease Stage 1 · Chronic Kidney Disease Stage 2
Research on Timing of Liraglutide Therapy in Patients With Obesity After Metabolic Surgery
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Obesity · Weight Loss · Bariatric Surgery
Preoperative Weight Loss for Open Abdominal Wall Reconstruction
Benjamin T. Miller
Abdominal Wall Hernia
Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.
Efficacy of Glucagon-like Peptide-1 Receptor Agonists According to Type 2 Diabetes Subtypes
Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari
Diabetes Mellitus, Type 2
Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.
Anti-obesity Pharmacotherapy and Inflammation
Louisiana State University Health Sciences Center in New Orleans
Obesity
4MB-LAS-P
4moving Biotech
Knee osteoarthritis
Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.
Effects of GH and Lirglutide on AgRP
Columbia University
Healthy · Growth Hormone Deficiency
Safety, Tolerability and Preliminary Efficacy of Sublingual Liraglutide in Patients With Type 2 Diabetes Mellitus
Biolingus
Diabete Type 2
Obesity Treatment to Improve Diabetes
Dasman Diabetes Institute
Type 1 Diabetes
A Study to Assess the Effects of CT-868 Treatment on Glucose Homeostasis in Participants with Type 1 Diabetes
Carmot Therapeutics, Inc.
Type 1 Diabetes
Effects of GLP-1RA on Body Weight, Metabolism and Fat Distribution in Overweight/Obese Patients With Type 2 Diabetes Mellitus
RenJi Hospital
Metformin · Obesity, Abdominal · Diabetes Mellitus, Type 2 · Abdominal Fat
A Research Study Comparing Wegovy to Other Weight Management Drugs in People Living With Obesity in America
Novo Nordisk A/S
Obesity
POSE2.0 With GLP-1 Agonist for Obesity Management
Emirates Health Services (EHS)
Obesity
Liraglutide Effectiveness in Preoperative Weight-loss for Bariatric-metabolic Surgery
Hospital Civil Juan I. Menchaca
Weight Loss · Bariatric Surgery Candidate · Obesity, Morbid
The Effect of GLP-1 Agonist in Patients With Hypothalamic Obesity: Prospective, Pilot Study
Seoul National University Hospital
Panhypopituitarism · Craniopharyngioma · Hypothalamic Obesity
LIGHT-MCI Trial: GLP-1 Agonist, SGLT2 Inhibitor, and DPP-4 Inhibitor for MCI Remission in Type 2 Diabetes
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Type 2 Diabetes Mellitus · Mild Cognitive Impairment
INSPIRE Turkey :A Research Study Looking at the Clinical Parameters Associated With Use and Discontinuation of Saxenda® in Local Clinical Practice in Turkey by Analysing Past Patient Medical Records
Novo Nordisk A/S
Obesity
Glucagon-like Peptide 1 (GLP1) Receptor Agonists and Mental Health
King's College London
Diabetes Mellitus · Obesity · Mental Health Issue
Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.
Efficacy and Safety Of Different Regimens In Patients With Type 2 Diabetes Receiving Intensive Insulin Therapy
Xiangya Hospital of Central South University
Type 2 Diabetes Mellitus
Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.
Safety, Tolerability and Pharmacokinetics of Intraarticular 4P004 Single Dose in Patient With KL 2-4 Osteoarthritic Knee
4Moving Biotech
Knee Osteoarthritis
A Study of LY3537021 in Healthy Participants
Eli Lilly and Company
Healthy
Effect of Liraglutide on Subclinical Atherosclerosis in Patients With Type 1 Diabetes Mellitus
David Sanchez Garcia
Diabetes Mellitus, Type 1
Outcome of Overweight AF Patients Following Ablation With a Potential Weight Loss Medication ( GOAL-AF )
University Hospital Birmingham
Atrial Fibrillation · Recurrence · Overweight and Obesity · Liraglutide
Efficacy of Liraglutide Therapy in Patients With IPAA
University of North Carolina, Chapel Hill
Pouchitis · Irritable Pouch Syndrome
Effect of Liraglutide on Weight Loss in Patients Who Have Undergone Revisional Bariatric Surgeries.
General Committee of Teaching Hospitals and Institutes, Egypt
Morbid Obesity
Endoscopic Ultrasound Guided Gastric Botulinum Toxin Injections Versus Glucagon Like Peptide 1 Receptor Agonist in Weight Loss
Mansoura University
Obesity
Exploring how oxygen therapy and smart limb exercises can help treat diabetes-related leg artery disease
The Second Hospital of Hebei Medical University
Lower limb rehabilitation training for patients with diabetes and lower extremity arterial disease (LEAD)
A Research Study About Weight Loss and Treatment Patterns With the Use of Saxenda® in Adults in Real-life Settings in Switzerland
Novo Nordisk A/S
Obesity or Overweight
Effects of XW003 Versus Liraglutide on Body Weight of Adult Participants With Obesity
Sciwind Biosciences APAC CO Pty. Ltd.
Obesity
Use of a GLP-1R Agonist to Treat Opioid Use Disorder
Milton S. Hershey Medical Center
Opiate Substitution Treatment · Opioid-Related Disorders
Comparative Effectiveness and Safety of Four Second Line Pharmacological Strategies in Type 2 Diabetes Study
Brigham and Women's Hospital
Cardiovascular Events · Type2 Diabetes · Renal Disease
A Randomized Phase 1 Study of Liralutide Injection in Healthy Chinese Subjects
The Affiliated Hospital of Qingdao University
Therapeutic Equivalency
Comparison of Type 2 Diabetes Pharmacotherapy Regimens
Kaiser Permanente
Type 2 Diabetes Mellitus · Cardiovascular Diseases
Is Saxenda® a Viable Treatment of Obese Patients in Forensic Psychiatry?
Anders Fink-Jensen, MD, DMSci
Mental Disorder · Metabolic Disturbance · Feasibility · Overweight and Obesity
Liraglutide (Saxenda(R)) in Adolescents With Obesity After Sleeve Gastrectomy
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Obesity · Status Post Sleeve Gastrectomy
A Study in Men With Overweight to Test How Well Different Doses of BI 1820237 Are Tolerated When Given as an Injection Alone or in Combination With Liraglutide
Boehringer Ingelheim
Healthy
Liraglutide Plus Megestrol Acetate in Endometrial Atypical Hyperplasia
Xiaojun Chen
Atypical Endometrial Hyperplasia · Obese · Fertility Issues
SCALE KIDS: Research Study to Look at How Well a New Medicine is at Lowering Weight in Children With Obesity
Novo Nordisk A/S
Obesity
NN8022-4392
Novo Nordisk A/S
Obesity
Anti-diabetic Drugs and Fatty Liver Management
Alexandria University
Fatty Liver, Nonalcoholic · Diabetes Mellitus, Type 2
Liraglutide and Peripheral Artery Disease
University of Campania Luigi Vanvitelli
Type 2 Diabetes · Peripheral Arterial Disease
Liraglutide Improve Cognitive Function in Patients With Type 2 Diabetes Mellitus
Third Military Medical University
Type 2 Diabetes Mellitus
Efficacy and Tolerance of Liraglutide for Weight Loss in Obese Type 2 Diabetic Hemodialysis Patients
Fondation Hôpital Saint-Joseph
Diabetes Mellitus, Type 2 · Hemodialysis · Obese
Liraglutide for Low-responders After Bariatric Surgery
Zuyderland Medisch Centrum
Obesity · Obesity, Morbid
Targeting Beta-cell Failure in Lean Patients With Type 2 Diabetes
University of Leeds
Diabetes Mellitus, Type 2
Effect of Liraglutide on the Metabolic Profile in Patients With Type 2 Diabetes and Cardiovascular Disease
RWTH Aachen University
Type 2 Diabetes · Cardiovascular Diseases
Effects of Exercise and GLP-1 Agonism on Muscle Microvascular Perfusion and Insulin Action in Adults With Metabolic Syndrome
University of Virginia
Metabolic Syndrome
Study of the Cardiometabolic Effects of Obesity Pharmacotherapy
National and Kapodistrian University of Athens
Obesity · Blood Pressure
EMI-EHP Weight Management and Type 2 Diabetes Pragmatic Trial
The Cleveland Clinic
Type 2 Diabetes · Obesity
Antigen-Lipid-Driven Monoclonal Gammopathies Targeting Epicardial Fat
University of Miami
Monoclonal Gammopathies · Overweight · Obesity
A Study of Tirzepatide in Overweight and Very Overweight Participants
Eli Lilly and Company
Obesity · Overweight
The Efficacy and Safety of Liraglutide on Body Weight Loss in Obese and Overweight Patients
Shanghai Zhongshan Hospital
Obese · Overweight
A Pharmacokinetic Study Comparing the Liraglutide Injection (RD12014) and Victoza® in Healthy Chinese Subjects
Sunshine Lake Pharma Co., Ltd.
Type 2 Diabetes
Gut Microbiome Changes Following Liraglutide Treatment in Obese Subjects or Overweight Subjects With Co-morbidities
Xiangya Hospital of Central South University
Obesity
Harmonizing RCT-Duplicate Emulations In A Real World Replication Program (HARRP)
AstraZeneca
Type 2 Diabetes Mellitus
Efficacy and Safety of Liraglutide on Body Weight in Obese Subjects or Overweight Subjects With Co-morbidities
Xiangya Hospital of Central South University
Obesity
Efficacy and Safety of Liraglutide in Type 2 Diabetes With Lower Extremity Arterial Disease
Second Affiliated Hospital, Zhejiang University, School of Medicine
Type 2 Diabetes · Peripheral Vascular Disorder Due to Diabetes Mellitus
Study to Assess the Efficacy and Safety of Liraglutide in the Treatment of Type 2 Diabetes
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Type 2 Diabetes
The Effect of Liraglutide on the GIT
Universitaire Ziekenhuizen KU Leuven
Obesity
Liraglutide in the Prevention of Type 2 Diabetes After Gestational Diabetes
Turku University Hospital
Gestational Diabetes
The effect of liraglutide on MMC activity, gastrointestinal hormones, hunger ratings and ad libitum food intake in healthy volunteers.
UZ Leuven
Obesity
Dulaglutide Versus Liraglutide in Obese Type 2 Diabetic Adolescents Using Metformin
Corporacion Parc Tauli
Type 2 Diabetes Treated With Insulin · Obesity · Adolescent Obesity
Life Style Modification Medical and Surgical Management in Patients With Obesity
Marmara University
Obesity · Weight Change, Body · Obesity; Endocrine · Obesity, Metabolically Benign
Effect of Liraglutide vs CPAP on Cardiometabolic Outcomes in Obstructive Sleep Apnea
St Vincent's University Hospital, Ireland
Sleep Apnea, Obstructive
Liraglutide Actions on the Liver: Effects on Glucose Phosphorylation
Cedars-Sinai Medical Center
Type 2 Diabetes
Effects of Benaglutide on Weight and Gut Microbiota in Obese Patients
Xiangya Hospital of Central South University
Obesity
Clinical Study on the Improvement of Diabetic Neuropathic Pain by Liraglutide
Fudan University
Diabetic Neuropathic Pain
Research Study to Investigate How Well Semaglutide Works Compared to Liraglutide in People Living With Overweight or Obesity
Novo Nordisk A/S
Overweight · Obesity
Replication of the LEAD-2 Diabetes Trial in Healthcare Claims Data
Brigham and Women's Hospital
Diabetes
Liraglutide in Acute Minor Ischemic Stroke or High-risk Transient Ischemic Attack Patients With Type 2 Diabetes Mellitus
First Affiliated Hospital of Jinan University
Ischemic Stroke · Transient Ischemic Attack · Type 2 Diabetes Mellitus
Comparing Efficacy and Safety of CinnaGen-liraglutide Versus Victoza® in Patients With Type II Diabetes
Cinnagen
Diabetes Mellitus, Type 2
Human Bioequivalence Test of Liraglutide Injection
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Type 2 Diabetes
Cardiovascular Outcomes and HbA1c Among Patients With Type 2 Diabetes Newly Initiating GLP1RAs vs Basal Insulin
Brigham and Women's Hospital
Diabetes Mellitus, Type 2
Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.
Liraglutide Effect in Atrial Fibrillation
University of Miami
Atrial Fibrillation
A Research Study Looking at How Victoza® Works in People With Type 2 Diabetes in Iran, Followed in Local Clinical Routine
Novo Nordisk A/S
Diabetes Mellitus, Type 2
Treatment of Bile Acid Malabsorption With Liraglutide
Filip Krag Knop
Bile Acid Malabsorption
Research Study Investigating How Well NNC0174-0833 Works in People Suffering From Overweight or Obesity.
Novo Nordisk A/S
Overweight · Obesity
Effect of Exercise and/or Liraglutide on Vascular Dysfunction and Insulin Sensitivity in Type 2 Diabetes ( ZQL007)
University of Virginia
Type2 Diabetes
The Gut Microbiome in Women With Polycystic Ovary Syndrome
Universitaire Ziekenhuizen KU Leuven
PCOS · Obesity · Metabolic Syndrome
Incretin and Treatment With Inhibition of Sodium-glucose Cotransporter-2 Combination Insights Into Mechanisms Implicated in Congestive Heart Failure: "NATRIURETIC" Trial
University Health Network, Toronto
Type 2 Diabetes Mellitus
3mg Liraglutide for Overweight or Obesity
University Hospitals Coventry and Warwickshire NHS Trust
Overweight · Obesity · Infertility, Female
IDegLira HIGH Trial
Emory University
Diabetes Mellitus
Liraglutide-bolus vs Glargine-bolus Therapy in Overweight/Obese Type 2 Diabetes Patients (LiraGooD)
The First Affiliated Hospital of Xiamen University
Type 2 Diabetes Patients · Overweight and Obesity · Hyperglycaemia (Diabetic)
Effect of Liraglutide on Microbiome in Obesity
Federico II University
Obesity · Weight Loss · Microbiome
To Predict Weight Loss Response to Liraglutide (Saxenda®), From fMRI-based Determination of Food Cue Reactivity
Texas Tech University
Obesity
Real World Effectiveness of Combining an Employer-based Weight Management Program With Medication for Chronic Weight Management in Employees With Obesity
Novo Nordisk A/S
Obesity
Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.
GLP-1 REceptor Agonists and Real World EvIdeNce
University of Padova
Type 2 Diabetes
Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.
Daily Liraglutide for Nicotine Dependence
Rebecca Ashare
Smoking Cessation · Weight, Body
Multiple Ascending Dose Study of AMG 598 in Adults With Obesity
Amgen
Obesity
A Study Using Medical Records of Danish People With Type 2 Diabetes Comparing Empagliflozin and Glucagon-Like Peptide-1 Receptor Agonists (GLP1-RA) in the Occurrence of Serious Cardiovascular Outcomes
Boehringer Ingelheim
Diabetes Mellitus, Type 2
Effects of Liraglutide on the Cognitive Function in Patients With Type 2 Diabetes Mellitus
Third Military Medical University
Type 2 Diabetes Mellitus
Liraglutide 3mg (Saxenda) on Weight, Body Composition, Hormonal and Metabolic Parameters in Obese Women With PCOS
Woman's
Pre Diabetes · Polycystic Ovary Syndrome · Obesity Android
The Use of Liraglutide in Brain Death
Hospital de Clinicas de Porto Alegre
Brain Death
Effects of GLP-1 RAs on Weight and Metabolic Indicators in Obese Patients
Xiangya Hospital of Central South University
Obesity
Liraglutide Effects on Epicardial Fat Inflammatory Genes
University of Miami
Type2 Diabetes · Coronary Artery Disease
Evaluation of Liraglutide 3.0mg in Patients With Poor Weight-loss and a Suboptimal Glucagon-like Peptide-1 Response
University College, London
Obesity
Targeting Beta Cell Dysfunction With Liraglutide or Golimumab in Longstanding T1D
Carla Greenbaum, MD
Type 1 Diabetes Mellitus
A Regulatory Post-marketing Surveillance (rPMS) Study to Evaluate the Safety and Effectiveness of Saxenda®(Liraglutide 3.0 mg) in Obese Patients and Overweight Patients With Obesity-related Comorbidities in Routine Clinical Practice in Korea.
Novo Nordisk A/S
Obesity · Overweight
Liraglutide and the management of overweight and obesity in people with schizophrenia
Southern Health NHS Foundation Trust
Schizophrenia
Effect of Liraglutide on Neural Responses to High Fructose Corn Syrup in Individuals With Obesity.
Yale University
Obesity, Childhood · Neural Development
A Study to Investigate the Effect of MEDI0382 on Hepatic Glycogen Metabolism in Overweight and Obese Subjects With Type 2 Diabetes Mellitus.
MedImmune LLC
Type 2 Diabetes Mellitus
In Market Utilisation of Liraglutide Used for Weight Management in the UK: a Study in the CPRD Primary Care Database
Novo Nordisk A/S
Obesity · Overweight
Effects of GLP-1 Agonists on CArdiac Steatosis Evaluated by Magnetic Resonance Imaging
Centre Hospitalier Universitaire Dijon
Type II Diabetes
Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.
A Study to Evaluate the Safety and Efficacy of JNJ-64565111 in Non-diabetic Severely Obese Participants
Janssen Research & Development, LLC
Obesity
Reward Mechanisms in Obesity
Zoltan Pataky
Obesity
Effects of Liraglutide in Chronic Obstructive Pulmonary Disease
Claus Bogh Juhl
Pulmonary Disease, Chronic Obstructive
Individualized Obesity Pharmacotherapy
Mayo Clinic
Obesity
The Effect and the Pharmacogenomics Study of Liraglutide in Obese Patients
Xiangya Hospital of Central South University
Obesity
Pilot Study of the Effect of Liraglutide 3.0 mg on Weight Loss and Gastric Functions in Obesity
Michael Camilleri, MD
Obesity
Saxenda in Obesity Services (STRIVE Study)
University of Leicester
Obesity · Weight Loss · Diabetes Mellitus
Effect of Liraglutide on Vascular Inflammation in Type-2 Diabetes
Steno Diabetes Center Copenhagen
Diabetes Mellitus, Type 2
Liraglutide on Decreasing Parenteral Support in Short Bowel Patients (SLIPS)
Imperial College London
Short Bowel Syndrome
A Trial to Investigate the Single Dose Pharmacokinetics of Insulin Degludec/Liraglutide Compared With Insulin Degludec and Liraglutide in Healthy Chinese Subjects
Novo Nordisk A/S
Diabetes · Diabetes Mellitus, Type 2
Binge Eating Liraglutide Intervention
Kelly Allison
Binge-Eating Disorder
Replication of the LEADER Diabetes Trial in Healthcare Claims
Brigham and Women's Hospital
Diabetes
The Effect of Liraglutide on Pancreatic Hormones and Its Size
Nicolai Jacob Wewer Albrechtsen
Obesity
Stem Cell Mobilization (Plerixafor) and Immunologic Reset in Type 1 Diabetes (T1DM)
University of Alberta
Diabetes Mellitus, Type 1
A Study to Evaluate the Efficacy and Safety of MEDI0382 in the Treatment of Overweight and Obese Subjects With Type 2 Diabetes
AstraZeneca
Diabetes Mellitus, Type 2
Prognostic Predictors of Response to Hypoglycemic Therapy
Federal State Budgetary Institution, V. A. Almazov Federal North-West Medical Research Centre, of the Ministry of Health
Diabetes Mellitus, Type 2
Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.
The Effect of GLP-1 Agonists Versus OCs on Reproductive Disorders and Cardiovascular Risks in Overweight PCOS
Xinqiao Hospital of Chongqing
Polycystic Ovary Syndrome (PCOS) · Overweight · Obesity
Research Study Comparing a New Medicine Semaglutide to Liraglutide in People With Type 2 Diabetes
Novo Nordisk A/S
Diabetes · Diabetes Mellitus, Type 2
Effect of GLP-1 Receptor Agonism After Sleeve Gastrectomy
Mayo Clinic
Obesity
A Study of LY3325656 in Healthy Participants and Participants With Type 2 Diabetes
Eli Lilly and Company
Diabetes Mellitus, Type 2
A Trial Comparing Insulin Degludec/Liraglutide, Insulin Degludec, and Liraglutide in Chinese Subjects With Type 2 Diabetes Inadequately Controlled on Oral Antidiabetic Drugs (OADs)
Novo Nordisk A/S
Diabetes · Diabetes Mellitus, Type 2
Clinical Efficacy and Safety of Using 3.0mg Liraglutide to Treat Weight Regain After Roux-en-Y Gastric Bypass Surgery
NYU Langone Health
Obesity
Title: Therapeutic Targets in African-American Youth With Type 2 Diabetes
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type 2 Diabetes
Cardiovascular Effects of GLP-1 Receptor Activation
Vanderbilt University Medical Center
Obesity · PreDiabetes
Saxenda® in Obese or Overweight Patients With Stable Bipolar Disorder (Investigator Initiated)
Lindner Center of HOPE
Bipolar Disorder · Obesity
Safety and Efficacy of Liraglutide in Parkinson's Disease
Cedars-Sinai Medical Center
Parkinson Disease
A pre-pregnancy study examining the effects of an intensive lifestyle package supported with Liraglutide treatment, a medication equivalent to a natural hormone produced in the stomach, in obese women with previous history of pregnancy diabetes
Clinical Research Centre - University College Dublin
1. Gestational diabetes 2. Glucose intolerance 3. Obesity
LIRA-ADD2SGLT2i - Liraglutide Versus Placebo as add-on to SGLT2 Inhibitors.
Novo Nordisk A/S
Diabetes · Diabetes Mellitus, Type 2
Methodology Study To Examine 6-Week Food Intake With Liraglutide In Obese Subjects
Pfizer
Obesity
Effect and Safety of Liraglutide 3.0 mg in Subjects With Overweight or Obesity and Type 2 Diabetes Mellitus Treated With Basal Insulin
Novo Nordisk A/S
Metabolism and Nutrition Disorder · Obesity
Effect and Safety of Liraglutide 3.0 mg as an Adjunct to Intensive Behaviour Therapy for Obesity in a Non-specialist Setting
Novo Nordisk A/S
Metabolism and Nutrition Disorder · Obesity
Dose-response, Safety and Efficacy of Oral Semaglutide Versus Placebo and Versus Liraglutide, All as Monotherapy in Japanese Subjects With Type 2 Diabetes
Novo Nordisk A/S
Diabetes · Diabetes Mellitus, Type 2
Liraglutide as Additional Treatment to Insulin in Patients With Autoimmune Diabetes Mellitus
Second Xiangya Hospital of Central South University
Type 1 Diabetes Mellitus · Autoimmune Diabetes
Impact of Liraglutide 3.0 on Body Fat Distribution
University of Texas Southwestern Medical Center
Obesity, Visceral · Cardiovascular Diseases · Fat Disorder
Safety and Efficacy of Umbilical Cord Blood Regulatory T Cells Plus Liraglutide on Autoimmune Diabetes
Second Xiangya Hospital of Central South University
Type1 Diabetes Mellitus · Autoimmune Diabetes
Measurement of Alanine Aminotransaminase (ALT) Following Initiation of Antidiabetic Agents in Patients With Type 2 Diabetes in a Real-world Clinical Setting: a Retrospective Cohort Study
LMC Diabetes & Endocrinology Ltd.
T2DM (Type 2 Diabetes Mellitus) · Fatty Liver · NAFLD
Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.
In-market Utilisation of Liraglutide Used for Weight Management in Europe
Novo Nordisk A/S
Metabolism and Nutrition Disorder · Obesity
A Study to Assess the Safety and Efficacy of SAR425899 in Patients With Type 2 Diabetes Mellitus
Sanofi
Type 2 Diabetes Mellitus
GLIDE: Gastric band and Liraglutide Intervention in Diabetes Evolution
NIHR Guy's & St Thomas' NHS Foundation Trust (GSTFT)/King’s College London (KCL) Biomedical Research Centre
Specialty: Diabetes, Primary sub-specialty: Type 2; UKCRC code/ Disease: Metabolic and Endocrine/ Diabetes mellitus
HbA1c Variability in Type II Diabetes
Weill Cornell Medical College in Qatar
Diabetes Mellitus Type 2
Ultrasound of the Knee in Obese Patients With Knee Osteoarthritis; Weight Maintenance
Henrik Gudbergsen
Osteoarthritis · Obesity
Liraglutide 3 mg for Knee Osteoarthritis
Henrik Gudbergsen
Osteoarthritis · Obesity
Saxenda: Underlying Mechanisms and Clinical Outcomes
Beth Israel Deaconess Medical Center
Obesity
Multi-parametric Imaging of the Knee in Obese Patients With Knee Osteoarthritis; Weight Maintenance
Henrik Gudbergsen
Osteoarthritis · Obesity
Biomarkers in Obese Patients With Knee Osteoarthritis; Weight Maintenance
Henrik Gudbergsen
Osteoarthritis · Obesity
Changes in Skin Autoflouresence Following Weight Loss and Maintenance Using Liraglutide in Knee Osteoarthritis
Parker Research Institute
Osteoarthritis, Knee
Study to Assess the Efficacy of Liraglutide in Patients With Type 2 Diabetes Mellitus
Lecube, Albert, M.D.
Type 2 Diabetes
Effect of Liraglutide for Weight Management in Pubertal Adolescent Subjects With Obesity
Novo Nordisk A/S
Metabolism and Nutrition Disorder · Obesity
Clinical Study of Liraglutide in Improving Cardiac Function for Patients With Ischemic Cardiomyopathy
Chinese PLA General Hospital
Ischemic Cardiomyopathy
Lifestyle Modification and Liraglutide
University of Pennsylvania
Obesity
Liraglutide for HIV-associated Neurocognitive Disorder
Temple University
HIV Infection · Diabetes Mellitus Type 2 · Obesity · Overweight
Combined Effects of GLP-1 Analogue and Exercise on Maintenance of Weight Loss and Health After Very-low Calorie Diet
Signe Torekov
Obesity
Investigating Safety, Tolerability, PK and PD for Multiple Doses of NNC9204-0530 in Combination With Liraglutide in Male and Female Subjects Being Overweight or With Obesity
Novo Nordisk A/S
Metabolism and Nutrition Disorder · Obesity
Efficacy and Safety of Oral Semaglutide Versus Liraglutide and Versus Placebo in Subjects With Type 2 Diabetes Mellitus
Novo Nordisk A/S
Diabetes · Diabetes Mellitus, Type 2
Laparocopic Sleeve Gastrectomy With or Without Liraglutide in Obese Patients
Post Graduate Institute of Medical Education and Research, Chandigarh
Weight Loss
GLP-1/Basal Insulin Combination Therapy
Albany College of Pharmacy and Health Sciences
Type 2 Diabetes Mellitus
Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.
Efficacy and Safety of the Insulin Glargine/Lixisenatide Fixed Ratio Combination (FRC) Versus GLP-1 Receptor Agonist in Patients With Type 2 Diabetes, With a FRC Extension Period
Sanofi
Type 2 Diabetes Mellitus
Effect of Liraglutide on Clock Genes
Tel Aviv University
Type 2 Diabetes
Par-4 and Telomere-telomerase System in Type 2 Diabetes Patients Who Received GLP-1 or Metformin Treatment
Third Military Medical University
GLP-1；Metformin；Telomere-telomerase System；Par-4
Influence of Liraglutide, a GLP-1 Receptor Agonist, on Brown Adipose Tissue (BAT) Activity in Humans
University of Campinas, Brazil
Obesity · Type 2 Diabetes Mellitus
Effect of GLP-1 on Angiogenesis
Assistance Publique - Hôpitaux de Paris
Type 2 Diabetes
Timely Detection of Treatment Emergent Serious and Non-serious Adverse Events for Saxenda® in Mexican Patients
Novo Nordisk A/S
Obesity
The Effects of Liraglutide on Sudomotor Function and Inflammation in Type 2 Diabetes
Eastern Virginia Medical School
Autonomic Nervous System Diseases · Sweat Gland Diseases · Diabetic Neuropathy With Neurologic Complication
Improving Beta Cell Function in Mexican American Women With Prediabetes
Ohio State University
Pre-Diabetes
Efficacy in Controlling Glycaemia With Victoza® (Liraglutide) as add-on to Metformin vs. OADs as add-on to Metformin After up to 104 Weeks of Treatment in Subjects With Type 2 Diabetes
Novo Nordisk A/S
Diabetes · Diabetes Mellitus, Type 2
A Trial to Assess the Effects of Liraglutide on Gallbladder Emptying in Overweight and Obese Subjects.
Novo Nordisk A/S
Metabolism and Nutrition Disorder · Obesity
A Trial to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Liraglutide in Obese Children Aged 7 to 11 Years
Novo Nordisk A/S
Metabolism and Nutrition Disorder · Obesity
Incretin-based Therapy in Early Diagnosed Type 1 Diabetes
University of Oulu
Type 1 Diabetes
Effects of Single Doses of Liraglutide and Dapagliflozin on Ketogenesis in Type 1 Diabetes
University at Buffalo
Type 1 Diabetes
Incretin-based Therapy in Late Preclinical Type 1 Diabetes
University of Oulu
Type 1 Diabetes
Effect of Liraglutide on Diastolic Dysfunction on Cardiac MRI in Type 2 Diabetes Patients
Rigshospitalet, Denmark
Diabetes Mellitus Type 2 · Diastolic Dysfunction · Cardiac MRI · Myocardial Perfusion
The effects of liraglutide in controlling blood sugar and weight in poor-responders to bariatric surgery
Imperial College London
Topic: Diabetes, Metabolic and endocrine disorders; Subtopic: Type 2, Metabolic and Endocrine (all Subtopics); Disease: Diabetic Control, Metabolic & Endocrine (not diabetes)
Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.
Short Term Effect of Liraglutide Versus Vildagliptine on Insulin Secretion and Insulin Sensitivity in Type 2 Diabetes
Yaounde Central Hospital
Type 2 Diabetes Mellitus
Effects of GLP-1 on Chronic Heart Failure
Shi Yang
Heart Failure
Pilot Study of the Effect of Liraglutide on Weight Loss and Gastric Functions in Obesity
Mayo Clinic
Obesity
Study of the Safety and Tolerability of Switching to ITCA 650 in Patients With Type 2 Diabetes Receiving Liraglutide
Intarcia Therapeutics
Diabetes Mellitus, Type 2
Incretin-based Therapy in Preclinical Type 1 Diabetes in Adults
University of Oulu
Type 1 Diabetes
Glucagon-like Peptide-1 and Coronary Microvascular Dysfunction in Women With Angina Pectoris and no Coronary Stenosis
Eva Prescott
Microvascular Angina
A Trial Comparing the Efficacy and Safety of Insulin Degludec/Liraglutide, Insulin Degludec and Liraglutide in Japanese Subjects With Type 2 Diabetes Mellitus.
Novo Nordisk A/S
Diabetes · Diabetes Mellitus, Type 2
A Clinical Proof-of-principle Trial in Adult Subjects With Newly Diagnosed Type 1 Diabetes Mellitus Investigating the Effect of NNC0114-0006 and Liraglutide on Preservation of Beta-cell Function
Novo Nordisk A/S
Diabetes · Diabetes Mellitus, Type 1
Effect of Liraglutide for Weight Management in Paediatric Subjects With Prader-Willi Syndrome
Novo Nordisk A/S
Metabolism and Nutrition Disorder · Obesity
Weight Loss With Intensive Lifestyle Modifications Plus Bariatric Surgery Versus Liraglutide 3 mg
Catholic University of the Sacred Heart
Obesity
Effects of Agonists of Glucagon Like Peptide - 1 Receptors (GLP-1R) on Arterial Stiffness, Endothelial Glycocalyx and Coronary Flow Reserve in Patients With Coronary Artery Disease and Patients With Diabetes Mellitus
University of Athens
Type 2 Diabetes Mellitus · Coronary Artery Disease
Liraglutide Effect on Beta-cell Function in C-peptide Positive Type 1 Diabetes
Per-Ola Carlsson
Type 1 Diabetes
GLP-1 on Non-ST-Segment Elevation Myocardial Infarction
Chinese PLA General Hospital
Myocardial Infarction
Investigation of Safety and Efficacy of Once-daily Semaglutide in Obese Subjects Without Diabetes Mellitus
Novo Nordisk A/S
Metabolism and Nutrition Disorder · Obesity
Treatment of Hypoglycemia Following Gastric Bypass Surgery
Zealand University Hospital
Hypoglycemia · Obesity · Surgery
Dose-finding of Semaglutide Administered Subcutaneously Once Daily Versus Placebo and Liraglutide in Subjects With Type 2 Diabetes
Novo Nordisk A/S
Diabetes · Diabetes Mellitus, Type 2
Dapagliflozin As Additional Treatment To Liraglutide And Insulin In Patients With Type 1 Diabetes
University at Buffalo
Type 1 Diabetes Mellitus
Effect of Liraglutide on Cardiovascular Endpoints in Diabetes Mellitus Type 2 Patients of South Asian Descent
Leiden University Medical Center
Diabetes Mellitus Type 2 · Metabolic Syndrome · Cardiovascular Disease · Diastolic Dysfunction
The Effect of Liraglutide on Bone Turnover, Bone Mass and Bone Cell Function
University of Aarhus
Diabetes Complications · Osteoporosis
A Preliminary Study of the Efficacy and Safety of MK-8521 for Type 2 Diabetes (MK-8521-004)
Merck Sharp & Dohme LLC
Type II Diabetes Mellitus
A Trial Comparing the Efficacy and Safety of Liraglutide 1.8 mg/Day to Liraglutide 0.9 mg/Day in Japanese Subjects With Type 2 Diabetes Mellitus.
Novo Nordisk A/S
Diabetes · Diabetes Mellitus, Type 2
Effects of Victoza® Versus Lyxumia® on Gastroesophageal Reflux, Gastric Emptying and Gastric Acid Secretion
Profil Institut für Stoffwechselforschung GmbH
Diabetes Mellitus
Effects of Glucagon Like Peptide-1 on Haemodynamic Parameters
Chinese PLA General Hospital
Heart Failure
The Effect of GLP-1 on Postprandial Glucagon Secretion Independent of The Gastric Emptying Rate
Hvidovre University Hospital
Type 1 Diabetes
Low Dose Liraglutide and Metformin vs. High Dose Liraglutide Alone in Treatment of Obesity
University Medical Centre Ljubljana
Polycystic Ovary Syndrome · Obesity
Effects of Glucagon Like Peptide-1 on No-reflow
Chen Wei Ren, MD
Acute ST-segment Elevation Myocardial Infarction
Cognitive Dysfunction and Glucagon-like Peptide-1 Agonists
University Health Network, Toronto
Bipolar Disorder · Major Depressive Disorder
Psoriatic Arthritis Treated With Liraglutide Therapy: a QUality of Life and Efficacy Study
University Health Network, Toronto
Psoriatic Arthritis · Psoriasis · Impaired Glucose Tolerance · Type 2 Diabetes
Effects of Incretin on the Blood Pressure and Lipid in Patients With Overweight or Obese Diabetes
Third Affiliated Hospital of Third Military Medical University
Type 2 Diabetes · Overweight · Obesity · Masked Hypertension
Antiproteinuric Effects of Liraglutide Treatment
Steno Diabetes Center Copenhagen
Diabetic Kidney Disease
Long-Term Effectiveness of Liraglutide for Treatment of Type 2 Diabetes in Daily Practice
Novo Nordisk A/S
Diabetes · Diabetes Mellitus, Type 2
The Lira Pump Trial
Hvidovre University Hospital
Type 1 Diabetes
The Effect of Liraglutide Treatment on Postprandial Chylomicron and VLDL Kinetics, Liver Fat and de Novo Lipogenesis
Helsinki University Central Hospital
Type 2 Diabetes
Investigating the Effect of Liraglutide on the Endogenous Glucose Production During in Tye 1 Diabetes Subjects
Medical University of Graz
Type 1 Diabetes Mellitus
Effect of Liraglutide (Victoza) on Inflammation in Human Adipose Tissue and Blood
Stanford University
Diabetes Mellitus, Type 2 · Diabetes Mellitus, Type II · Diabetes Mellitus, Adult-Onset · Inflammation
Post-marketing Surveillance (Special Use-results Surveillance) on Use With Liraglutide (Victoza®)
Novo Nordisk A/S
Diabetes · Diabetes Mellitus, Type 2
The Effect of Liraglutide in Patients With Prediabetes and Kidney Failure
Bo Feldt-Rasmussen
Kidney Failure, Chronic · Prediabetic State
Testosterone Replacement Therapy and Liraglutide Effects on Weight Loss in Hypogonadism.
University Medical Centre Ljubljana
Hypogonadism · Obesity
The Effect of Simple Basal Insulin Titration, Metformin Plus Liraglutide for Type 2 Diabetes With Very Elevated HbA1c - The SIMPLE Study
University of Texas Southwestern Medical Center
Diabetes Mellitus, Type 2 · Diabetes
Effect of Combined Incretin-Based Therapy Plus Canagliflozin on Glycemic Control and the Compensatory Rise in Hepatic Glucose Production in Type 2 Diabetic Patients
The University of Texas Health Science Center at San Antonio
Type 2 Diabetes Mellitus
Pathophysiological Study of the Increase in Pancreatic Volume in Type 2 Diabetes Treatments.
Erasme University Hospital
Type 2 Diabetes · Incretinomimetics · Pancreas
To Evaluate the Effect of Liraglutide on Ambulatory Blood Pressure-A Pilot Study
Tulane University School of Medicine
Diabetes Mellitus, Non-Insulin-Dependent · Hypertensive Disease
The Effect of the GLP-1 Receptor Agonists on Blood Levels of Lipoprotein (a)
Hospital Universitari Vall d'Hebron Research Institute
Diabetes Mellitus Type 2
Investigate Safety, Tolerability and Pharmacokinetics for Single Doses of NNC9204-0530 Alone and in Combination With Liraglutide in Overweight to Obese But Otherwise Healthy Male Subjects
Novo Nordisk A/S
Metabolism and Nutrition Disorder · Obesity
The Effect of a Liraglutide on IVF in Obese PCOS
University Medical Centre Ljubljana
Polycystic Ovary Syndrome · Obesity · Infertility, Female
A Study of Once-Daily NNC0090-2746 in Participants With Type 2 Diabetes Inadequately Controlled With Metformin
Novo Nordisk A/S
Diabetes · Diabetes Mellitus Type 2
Efficacy Study of Liraglutide vs.Sitagliptin vs. Glargine on Liver Fat in T2DM Subjects
Sun Yat-sen University
Non-alcoholic Fatty Liver Disease
Investigating Bioequivalence Between Single-dose Liraglutide Administered Subcutaneously With Two Different Pen-injectors
Novo Nordisk A/S
Metabolism and Nutrition Disorder · Obesity
GLP-1 Response and Effect in Individuals With Obesity Causing Genetic Mutations
University of Copenhagen
Obesity
Effect of Repeated Administration of Liraglutide on Insulinogenic Indices
University of Tartu
Healthy
Study of Management of Pasireotide-induced Hyperglycemia in Adult Patients With Cushing's Disease or Acromegaly
Novartis Pharmaceuticals
Cushing's Disease · Acromegaly
Effects of Liraglutide on ER Stress in Obese Patients With Type 2 Diabetes
Temple University
Type 2 Diabetes
Antidiabetic Effects on Intrahepatic Fat
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Non-Alcoholic Fatty Liver Disease · Type2 Diabetes
The Differential Effects of Diabetes Therapy on Inflammation
University College Dublin
Diabetic Nephropathy · Type 2 Diabetes
Treatment of Diabetic Neuropathy With Liraglutide
Aalborg University Hospital
Diabetes Mellitus, Type 1 · Type 1 Diabetes Mellitus
Vitamin C and Liraglutide Effects on Hypoglycemia-induced Oxidative Stress, Inflammation and Endothelial Dysfunction in Type 1 Diabetes.
Anna Cruceta
Type 1 Diabetes Mellitus
The Efficacy and Safety of Liraglutide Adjunct to Insulin Treatment in Type 1 Diabetes
Novo Nordisk A/S
Diabetes · Diabetes Mellitus, Type 1
Short Term Weight Loss With Liraglutide and Metformin in Infertile Obese PCOS Patients
University Medical Centre Ljubljana
Obesity · PCOS
Preoperative Condition in Giant Obese Patients
Sana Klinikum Offenbach
Morbid Obesity · Bariatric Surgery Candidate
Effect of Liraglutide on Epicardial Fat in Subjects With Type 2 Diabetes
University of Miami
Type 2 Diabetes · Overweight · Obesity
Incretin-based Drugs and the Risk of Heart Failure
Canadian Network for Observational Drug Effect Studies, CNODES
Type 2 Diabetes Mellitus
Comparing Effects of Liraglutide and Bariatric Surgery on Weight Loss, Liver Function, Body Composition, Insulin Resistance, Endothelial Function and Biomarkers of Non-alcoholic Steatohepatitis (NASH) in Obese Asian Adults
Changi General Hospital
Non-alcoholic Fatty Liver Disease (NAFLD) · Weight Loss · Non-alcoholic Steatohepatitis (NASH)
Incretin-based Drugs and Pancreatic Cancer
Canadian Network for Observational Drug Effect Studies, CNODES
Diabetes Mellitus, Type 2
PDE-4 Inhibitor Roflumilast and GLP-1 Agonist Liraglutide in Polycystic Ovary Syndrome
University Medical Centre Ljubljana
PCOS · Obesity
Incretin-based Drugs and Acute Pancreatitis
Canadian Network for Observational Drug Effect Studies, CNODES
Diabetes Mellitus, Type 2
LIPT - Liraglutide in Polycystic Ovary Syndrome
Jens Faber
Polycystic Ovary Syndrome · Cardiovascular Disease
Liraglutide Hospital Discharge Trial
Emory University
Type 2 Diabetes
A Retrospective Database Assessment of Clinical Effectiveness in Type 2 Diabetes Patients Treated With Liraglutide From Primary Care Centers in Sweden
Novo Nordisk A/S
Diabetes · Diabetes Mellitus, Type 2
Effect of Victoza on Dietary Preferences and Habit in Patients With Type 2 Diabetes
Centre Hospitalier Universitaire Dijon
Type 2 Diabetes · Overweight
Roux-en-Y Gastric Bypass for BMI 27-32 Type 2 Diabetes Versus Best Medical Treatment
Khoo Teck Puat Hospital
Type II Diabetes in Subjects BMI 27 to 32
Liraglutide in Newly Onset Type 1 Diabetes.
Hvidovre University Hospital
Diabetes Mellitus, Type 1
A Comparison of Two Treatment Strategies in Older Participants With Type 2 Diabetes Mellitus (T2DM)
Eli Lilly and Company
Diabetes Mellitus, Type 2
Efficacy and Safety of Liraglutide Versus Sulphonylurea Both in Combination With Metformin During Ramadan in Subjects With Type 2 Diabetes
Novo Nordisk A/S
Diabetes · Diabetes Mellitus, Type 2
Perioperative Insulin, GIK or GLP-1 Treatment in Diabetes Mellitus
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Diabetes Mellitus Type II
Liraglutide to Improve corONary Haemodynamics During Exercise streSS
King's College London
Ischaemic Heart Disease · Coronary Heart Disease · Chronic Stable Angina
Liraglutide as Add on Therapy on Metformin in Women With Polycystic Ovary Syndrome
University Medical Centre Ljubljana
PCOS · Obesity
Evaluating Liraglutide in Alzheimer's Disease
Imperial College London
Alzheimer's Disease
Glycaemic Control of Weekly LAPS-Exendin Versus Placebo in Subjects of Type 2 Diabetes
Hanmi Pharmaceutical Company Limited
Type 2 Diabetes
Liraglutide Efficacy on Glucocorticoid Induced Hyperglycemia in Patients High Risk for Diabetes
Rabin Medical Center
Glucocorticoid Induced Hyperglycemia
Effects of Liraglutide in Young Adults With Type 2 DIAbetes (LYDIA)
University of Leicester
Type 2 Diabetes Mellitus · Cardiovascular Disease
Efficacy and Safety of Switching From Sitagliptin to Liraglutide in Subjects With Type 2 Diabetes Not Achieving Adequate Glycaemic Control on Sitagliptin and Metformin
Novo Nordisk A/S
Diabetes · Diabetes Mellitus, Type 2
The Efficacy and Safety of Liraglutide Compared to Sitagliptin, Both in Combination With Metformin in Chinese Subjects With Type 2 Diabetes
Novo Nordisk A/S
Diabetes · Diabetes Mellitus, Type 2
A Phase 1b Study of LAPS-Exendin in Subjects of Type 2 Diabetes Mellitus
Hanmi Pharmaceutical Company Limited
Diabetes Mellitus
Investigating the Safety Profile of Liraglutide Under Normal Conditions of Use in Korean Subjects With Type 2 Diabetes Mellitus
Novo Nordisk A/S
Diabetes · Diabetes Mellitus, Type 2
Study of the Safety and Efficacy of MK-8521 Compared to Placebo and a Diabetes Drug in Participants With Type 2 Diabetes Mellitus (MK-8521-003)
Merck Sharp & Dohme LLC
Diabetes Mellitus
Effect of Liraglutide on Cardiovascular Endpoints in Diabetes Mellitus Type 2 Patients
Leiden University Medical Center
Diabetes Mellitus Type 2 · Metabolic Syndrome · Cardiovascular Disease · Diastolic Dysfunction
Efficacy Study of Glucagonlike Peptide-1 to Treat Reperfusion Injury
Chen Wei Ren, MD
Acute Myocardial Infarction
The Efficacy and Safety of Liraglutide as Adjunct Therapy to Insulin in the Treatment of Type 1 Diabetes
Novo Nordisk A/S
Diabetes · Diabetes Mellitus, Type 1
Efficacy and Safety of Liraglutide Versus Lixisenatide as add-on to Metformin in Subjects With Type 2 Diabetes
Novo Nordisk A/S
Diabetes · Diabetes Mellitus, Type 2
Umbilical Cord Mesenchymal Stem Cells and Liraglutide in Diabetes Mellitus
Diabetes Care Center of Nanjing Military Command
Type 2 Diabetes
Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.
Effects of Liraglutide on Hippocampal Structure and Function in Aging Adults With Prediabetes
Stanford University
Insulin Resistance · Dementia
Antidiabetic Effects of Adding a DPP-4 Inhibitor to Pre-Existing Treatment With an Incretin Mimetic in Patients With T2D
Michael A. Nauck
Type 2 Diabetes
Retrospective Collection of Effectiveness and Safety Data From Patients Treated With Liraglutide or DPP-4 Inhibitor in Primary Care in Europe
Novo Nordisk A/S
Diabetes · Diabetes Mellitus, Type 2
Randomisation to Endobarrier Alone Versus With Incretin Analogue in SustainEd Diabesity (REVISE-Diabesity)
Sandwell & West Birmingham Hospitals NHS Trust
Type 2 Diabetes · Obesity · Diabesity
A Study of LY3025876 in Participants With Diabetes
Eli Lilly and Company
Type 2 Diabetes Mellitus
Incretin and KATP Channels
Katarina Kos
Healthy Subjects
Effect of Glucagon-like Peptide 1 (GLP-1) on Microvascular Myocardial Function in Patients With Type 2 Diabetes.
Bispebjerg Hospital
Type 2 Diabetes · Microvascular Dysfunction
A Comparative Effectiveness Study of Major Glycemia-lowering Medications for Treatment of Type 2 Diabetes
GRADE Study Group
Type 2 Diabetes · Comparative Effectiveness of Glycemia-lowering Medications
Prevention and Treatment Of Diabetes Complications With Gastric Surgery or Intensive Medicines
Pontificia Universidad Catolica de Chile
Type 2 Diabetes
Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.
The Effect of Glucagon-like-peptide 1 (GLP-1) Receptor Agonism on Diabetic Kidney Disease
Karl Neff
Diabetic Kidney Disease
SAFEGUARD: Pleiotropic Effects of Incretin Based Therapies
Amsterdam UMC, location VUmc
Type 2 Diabetes
Does a GLP-1 Receptor Agonist Change Glucose Tolerance in Antipsychotic-treated Patients?
Psychiatric Centre Rigshospitalet
Impaired Glucose Tolerance Associated With Drugs
A Pilot Study of the Effects on Sleep Disordered Breathing (SDB) When Using the Drug Liraglutide for 4 Weeks
Children's Hospital Medical Center, Cincinnati
Sleep Apnea · Sleep Disordered Breathing
52 Week Trial of Liraglutide in Type 1 Diabetes
CHU de Quebec-Universite Laval
Type 1 Diabetes
Functional Impact of GLP-1 for Heart Failure Treatment (FIGHT)
Duke University
Acute Heart Failure
RISE Adult Medication Study
RISE Study Group
Prediabetes · Type 2 Diabetes
Differences in Endothelial Function Amongst Sitagliptin and Liraglutide Users
Anna Cruceta
DIABETES Mellitus Type 2 Not Well Controlled
The Effect of Liraglutide on Dietary Lipid Induced Insulin Resistance in Humans
Phoenix VA Health Care System
Insulin Resistance
Liraglutide as add-on to Insulin in Type 1 Diabetes
Hvidovre University Hospital
Diabetes · Diabetes Mellitus, Type 1
To Investigate the Safety, Tolerability and Pharmacodynamics of GSK2890457 in Healthy Volunteers and Subjects With Type 2 Diabetes
GlaxoSmithKline
Obesity
A Monotherapy Study to Evaluate the Efficacy and Safety of 2 Dose Levels of Albiglutide in Japanese Subjects With Type 2 Diabetes Mellitus (T2DM)
GlaxoSmithKline
Diabetes Mellitus, Type 2
A Randomised, Double-blind, Placebo-controlled Trial to Assess Safety, Tolerability and Pharmacokinetics of Liraglutide in Obese Adolescent Subjects Aged 12 to 17 Years
Novo Nordisk A/S
Metabolism and Nutrition Disorder · Obesity
Effect of Liraglutide on Automated Closed-loop Glucose Control in Type 1 Diabetes
Jennifer Sherr
Type 1 Diabetes
Effect of Liraglutide Combined With Short-term CSII on Long-term Glycemic Remission and β Cell Function
Sun Yat-sen University
Diabetes Mellitus, Type 2
Study of Immune Cells in Obese Patients With Type 2 Diabetes Mellitus Treated With Liraglutide
Hvidovre University Hospital
Type 2 Diabetes Mellitus
Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.
Blood Pressure Outcomes With Liraglutide Therapy
Mount Sinai Hospital, Canada
Type 2 Diabetes · Systolic Hypertension
Addition of Liraglutide to Patients With Type 2 Diabetes Treated With Multiple Daily Insulin Injections
Vastra Gotaland Region
Type 2 Diabetes Mellitus
Liraglutide Versus Insulin Mono-therapy in the Closed Loop Setting
Albert Einstein College of Medicine
Type 1 Diabetes
Effects of Liraglutide on Kidney Function in Type 2 Diabetic Patients
University of Aarhus
Type 2 Diabetes Mellitus
Liraglutide In Overweight Patients With Type 1 Diabetes
University at Buffalo
Type 1 Diabetes
Efficacy and Safety of Liraglutide in Combination With Metformin Compared to Metformin Alone, in Children and Adolescents With Type 2 Diabetes
Novo Nordisk A/S
Diabetes · Diabetes Mellitus, Type 2
Liraglutide in the Treatment of Type 1 Diabetes Mellitus
University at Buffalo
Type 1 Diabetes
Liraglutide in Type 1 Diabetes
University at Buffalo
Type 1 Diabetes
Anti-diabetic Effects of Liraglutide in Adolescents and Young Subjects With Type 1 Diabetes
University at Buffalo
Type 1 Diabetes
Influence of Appetite Related Hormones in Binge Eating Behaviour Among the Overweight and Obese
Universiti Kebangsaan Malaysia Medical Centre
Binge Eating Behaviour
GLP-1 and Non-exercise Activity Thermogenesis in RHZ
Maastricht University Medical Center
Type 2 Diabetes Mellitus
The Effect of Insulin Degludec in Combination With Liraglutide and Metformin in Subjects With Type 2 Diabetes Qualifying for Treatment Intensification
Novo Nordisk A/S
Diabetes · Diabetes Mellitus, Type 2
The Effect of Liraglutide Versus Placebo When Added to Basal Insulin Analogues With or Without Metformin in Subjects With Type 2 Diabetes
Novo Nordisk A/S
Diabetes · Diabetes Mellitus, Type 2
Effects of Obesity Treatments on Food Preferences and Metabolism
Imperial College London
Obesity · Type 2 Diabetes Mellitus
Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.
Glucagon-like Peptide (GLP) Utilization and Safety
GlaxoSmithKline
Diabetes Mellitus, Type 2
Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.
The Efficacy of Insulin Degludec/Liraglutide in Controlling Glycaemia in Adults With Type 2 Diabetes Inadequately Controlled on GLP-1 Receptor Agonist and OAD Therapy
Novo Nordisk A/S
Diabetes · Diabetes Mellitus, Type 2
The Microvascular Function of GLP-1 and Its Analogues
Katarina Kos
Type 2 Diabetes · Obesity
Time Course of the Blood Pressure Lowering Effect of Liraglutide Therapy in Type 2 Diabetes
Peter Rossing
Type 2 Diabetes
Study of Liraglutide in Individuals With Type 2 Diabetes Using Insulin
University of Manitoba
Type 2 Diabetes
The Effects of GLP-1 in Maturity-Onset Diabetes of The Young (MODY)
University Hospital, Gentofte, Copenhagen
Maturity-onset Diabetes of the Young
Effect of Liraglutide on Fatty Liver Content and Lipoprotein Metabolism
Centre Hospitalier Universitaire Dijon
Type 2 Diabetes
The Impact of Liraglutide on Glucose Tolerance and the Risk of Type 2 Diabetes in Women With Previous Pregnancy-induced Diabetes
Tina Vilsboll
Gestational Diabetes Mellitus
Phase 2b Multicenter, Randomized, Double-Blind, Placebo- and Active-Controlled, Parallel-Group Study to Assess the PD Response and Safety of Three Dose Levels of (PB1023) Injection Following 20 Weeks of Weekly SC Dosing in Adults With T2DM
PhaseBio Pharmaceuticals Inc.
Type 2 Diabetes Mellitus
Efficacy and Safety of Liraglutide Versus Placebo as add-on to Existing Diabetes Medication in Subjects With Type 2 Diabetes and Moderate Renal Impairment
Novo Nordisk A/S
Diabetes · Diabetes Mellitus, Type 2
Effect of Liraglutide in Obese Subjects With Moderate or Severe Obstructive Sleep Apnoea: SCALE™ - Sleep Apnoea
Novo Nordisk A/S
Metabolism and Nutrition Disorder · Obesity · Obstructive Sleep Apnoea
Liraglutide in Type 1 Diabetes
Steno Diabetes Center Copenhagen
Diabetes Mellitus, Type 1 · Overweight
GLP-1 Analogue Treatment in Uncontrolled Type 1 Diabetic Patients
Hadassah Medical Organization
Uncontrolled Type 1 Diabetic Patients
A Study Comparing the Effect of Dulaglutide With Liraglutide in Type 2 Diabetes
Eli Lilly and Company
Type 2 Diabetes
Combinatorial Therapy for Peristent Type 2 Diabetes After Gastric Banding
East Carolina University
Type 2 Diabetes · Gastric Banding
Liraglutide and Cardio-Metabolic Risk Markers
University of Palermo
Type-2 Diabetes
Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.
A Long-term Trial to Compare the Effects of Liraglutide and Sulphonylurea (Glimepiride) Both in Combination With Metformin on Clinical, Endothelial and Image Markers of Cardiovascular Risk in Patients With Type 2 Diabetes
Fundación Fernández-Cruz
Type 2 Diabetes
Liraglutide Effects on Memory in Healthy Subjects
University of Luebeck
Healthy
Liraglutide in Adolescents With Type 1 Diabetes
University at Buffalo
Type 1 Diabetes
The Effect of Liraglutide on the Treatment of Coronary Artery Disease and Type 2 Diabetes
Haugaard, Steen Bendix, M.D., DMSc
Coronary Artery Disease · Diabetes Mellitus, Type 2
Pharmacodynamic Effects of Lixisenatide Compared to Liraglutide in Patients With Type 2 Diabetes Not Adequately Controlled With Insulin Glargine With or Without Metformin
Sanofi
Type 2 Diabetes Mellitus
Efficacy and Safety of Liraglutide in Combination With Insulin Therapy Compared to Insulin Alone in Japanese Subjects With Type 2 Diabetes
Novo Nordisk A/S
Diabetes · Diabetes Mellitus, Type 2
Efficacy and Safety of Liraglutide in Subjects With Type 1 Diabetes Undergoing Islet Cell Transplantation
Novo Nordisk A/S
Diabetes · Diabetes Mellitus, Type 1
Liraglutide in Obesity and Diabetes: Identification of CNS Targets Using fMRI
Beth Israel Deaconess Medical Center
Diabetes · Effects of Liraglutide Administration on Brain Activity · Weight Loss · Hunger
A Study of LY2189265 in Japanese Participants With Type 2 Diabetes Mellitus
Eli Lilly and Company
Type 2 Diabetes Mellitus
Incretin Effect on the Immunological Phenotype
Medical University of Graz
Type 1 Diabetes
Liraglutide and Insulin Therapy in Patients With Type 2 Diabetes
Radboud University Medical Center
Type 2 Diabetes Mellitus
Liraglutide Use in Prader-Willi Syndrome
Vancouver General Hospital
Diabetes Mellitus Type 2 · Prader Willi Syndrome
The Effect of Liraglutide Adjunct to Insulin on Glucagon Response to Hypoglycaemia in Subjects With Type 1 Diabetes
Novo Nordisk A/S
Diabetes · Diabetes Mellitus, Type 1
Safety and Efficacy of Liraglutide in Combination With an OAD in Subjects With Type 2 Diabetes Insufficiently Controlled on OAD Alone
Novo Nordisk A/S
Diabetes · Diabetes Mellitus, Type 2
Adding Liraglutide to High Dose Insulin: Breaking the Cycle
Ildiko Lingvay
Type 2 Diabetes Mellitus · Obesity
Cooperation of Insulin and GLP-1 on Myocardial Glucose Uptake
Indiana University
Type 2 Diabetes
Vildagliptin Versus Liraglutide - Patient Preference After Receiving Both Medications
Novartis Pharmaceuticals
Type 2 Diabetes
Identifying Potential Effects of Liraglutide on Degenerative Changes
University of Aarhus
Alzheimers Disease
Liraglutide and Heart Failure in Type 2 Diabetes
Thomas Nystrom
Congestive Heart Failure · Type 2 Diabetes Mellitus
Effect of GLP-1 Analogs on Psoriasis in Type 2 Diabetic Patients
Cliniques universitaires Saint-Luc- Université Catholique de Louvain
Type 2 Diabetes · Psoriasis
Study of Effectiveness of Liraglutide Added to High Dose Insulin in Type II Diabetics
Mountain Diabetes and Endocrine Center
Diabetes Mellitus, Type II
Pretreatment of Patients Expecting Bariatric Surgery With the GLP-1 Analogon Liraglutid
Universitätsklinikum Hamburg-Eppendorf
Obesity
Liraglutide or Insulin in Real Life Usage in Patients With Diabetes Mellitus Type 2
Novo Nordisk A/S
Diabetes · Diabetes Mellitus, Type 2
Study of RO6807952 in Patients With Diabetes Mellitus Type 2
Hoffmann-La Roche
Diabetes Mellitus Type 2
Polycystic Ovary Syndrome and Liraglutide
University Medical Centre Ljubljana
PCOS · Obesity
Polycystic Ovary Syndrome and Liraglutide as Add-on Therapy on Metformin
University Medical Centre Ljubljana
PCOS · Obesity
The Effect of Liraglutide on Left Ventricular Function in Chronic Heart Failure Patients With and Without Type 2 Diabetes Mellitus
Flyvbjerg, Allan, DMSc
Hyperglycemia · Chronic Heart Failure
The Effect of Glucagon Like Peptide (GLP)-1 in Psoriasis
Annesofie Faurschou
Psoriasis
The Effects of Physical Training and GLP-1 Receptor Agonist Liraglutide Treatment in Patients With Type 2 Diabetes
Tina Vilsboll
Type 2 Diabetes
Safety, Tolerability and Pharmacokinetics of Liraglutide-depot in Healthy Subjects
Novo Nordisk A/S
Diabetes · Diabetes Mellitus, Type 2 · Healthy
Effects of Glucagon Like Peptide-1(GLP-1) and Liraglutide on Brain Satiety and Reward Circuits and Feeding Behavior in Diabetes
Amsterdam UMC, location VUmc
Obesity · Type 2 Diabetes
Liraglutide Treatment to Patients With Severe Renal Insufficiency
Bo Feldt-Rasmussen
Type 2 Diabetes Mellitus · End-stage Renal Disease
Comparison of the Efficacy and Safety of Two Intensification Strategies in Subjects With Type 2 Diabetes Inadequately Controlled on Basal Insulin and Metformin
Novo Nordisk A/S
Diabetes · Diabetes Mellitus, Type 2
Non-Interventional Study on Safety of Liraglutide in Subjects With Type 2 Diabetes
Novo Nordisk A/S
Diabetes · Diabetes Mellitus, Type 2
Combined Liraglutide and Metformin Therapy in Women With Previous Gestational Diabetes Mellitus (GDM)
Woman's
Gestational Diabetes Mellitus · Type 2 Diabetes Mellitus · Metabolic Syndrome · Impaired Glucose Tolerance
GLP-1 Receptors in Normal Skin and Skin From Patients With Psoriasis
University Hospital, Gentofte, Copenhagen
Reduction of Psoriasis Following Liraglutide Therapy in Terms of PASI and DLQI
Evaluating the Safety and Effectiveness of Liraglutide in Subjects With Type 2 Diabetes
Novo Nordisk A/S
Diabetes · Diabetes Mellitus, Type 2
Effect of Liraglutide on Body Weight in Non-diabetic Obese Subjects or Overweight Subjects With Co-morbidities: SCALE™ - Obesity and Pre-diabetes
Novo Nordisk A/S
Metabolism and Nutrition Disorder · Obesity
Effect of Liraglutide on Body Weight in Overweight or Obese Subjects With Type 2 Diabetes: SCALE™ - Diabetes
Novo Nordisk A/S
Metabolism and Nutrition Disorder · Obesity
Evaluation of the Glucoregulatory Effects of Glucagon-like Peptide-1 Receptor (GLP-1 Receptor) Activation in Participants With Type 2 Diabetes Mellitus (MK-0000-222)
Merck Sharp & Dohme LLC
Type 2 Diabetes Mellitus
Dual Action of Liraglutide and Insulin Degludec in Type 2 Diabetes: A Trial Comparing the Efficacy and Safety of Insulin Degludec/Liraglutide, Insulin Degludec and Liraglutide in Subjects With Type 2 Diabetes
Novo Nordisk A/S
Diabetes · Diabetes Mellitus, Type 2
Study of Liraglutide Versus Insulin on Liver Fat Fraction in Patients With Type 2 Diabetes
Centre hospitalier de l'Université de Montréal (CHUM)
Nonalcoholic Fatty Liver Disease · Nonalcoholic Steatohepatitis · Type 2 Diabetes
Trial for People With Established Type 2 Diabetes During Ramadan
University of Leicester
Type 2 Diabetes
Comparison of Two Treatment Regimens (Sitagliptin Versus Liraglutide) on Participants Who Failed to Achieve Good Glucose Control on Metformin Alone (MK-0431-403)
Merck Sharp & Dohme LLC
Diabetes Mellitus, Type 2
DIabetes REsearCh on Patient sTratification (DIRECT): GLP-1R Agonists
University of Dundee
Diabetes
Safety and Tolerability of Insulin Degludec/Liraglutide (A3) in Healthy Subjects
Novo Nordisk A/S
Diabetes · Healthy
Observational Study on Effectiveness and Safety of Liraglutide in Subjects With Type 2 Diabetes
Novo Nordisk A/S
Diabetes · Diabetes Mellitus, Type 2
GLP-1 and Microvascular Function in Type 2 Diabetes
Royal Devon and Exeter NHS Foundation Trust
Type 2 Diabetes
Impact of Liraglutide on Sensory Perception, Sensory Specific Satiety, Liking and Wanting in Type 2 Diabetic Patients
Centre Hospitalier Universitaire Dijon
Type 2 Diabetes Mellitus · Overweight
LIraglutide and Beta-cell RepAir (LIBRA) Study
Mount Sinai Hospital, Canada
Type 2 Diabetes
A Post Marketing Surveillance (PMS) Study of Liraglutide in Subjects With Type 2 Diabetes Mellitus in India
Novo Nordisk A/S
Diabetes · Diabetes Mellitus, Type 2
The Influence of Liraglutide on the Reward Properties of Food: an fMRI Study on Healthy Volunteers
Medical University of Vienna
Healthy Human Male Subjects
Liraglutide as Additional Treatment in Patients With Type 1 Diabetes Mellitus
University at Buffalo
Type 1 Diabetes Mellitus
Observational Study on Efficacy and Safety of Liraglutide in Subjects With Type 2 Diabetes
Novo Nordisk A/S
Diabetes · Diabetes Mellitus, Type 2
Liraglutide Effect and Action in Diabetes: Evaluation of Cardiovascular Outcome Results
Novo Nordisk A/S
Diabetes · Diabetes Mellitus, Type 2
Liraglutide Efficacy and Action in Non-Alcoholic Steatohepatitis
University of Birmingham
Nonalcoholic Steatohepatitis
Effects of Lixisenatide Compared to Liraglutide on the Postprandial Plasma Glucose in Patients With Type 2 Diabetes
Sanofi
Type 2 Diabetes Mellitus
Efficacy Assessment of Insulin Glargine Versus LiraglutidE After Oral Agents Failure
Sanofi
Diabetes Mellitus, Type 2
Do women with polycystic ovary syndrome have increased cardiovascular risk compared to normal controls and could this risk be reduced by liraglutide?
Hull and East Yorkshire Hospitals NHS Trust (UK)
Polycystic Ovary Syndrome
A Study to Determine the Efficacy and Safety of Albiglutide as Compared With Liraglutide.
GlaxoSmithKline
Diabetes Mellitus, Type 2
Impact of Liraglutide on Endothelial Function and Microvascular Blood Flow in Type 2 Diabetes Mellitus
ikfe-CRO GmbH
Diabetes Mellitus, Type 2
Safety and Efficacy of Exenatide Once Weekly Versus Liraglutide in Subjects With Type 2 Diabetes
AstraZeneca
Type 2 Diabetes Mellitus
Liraglutide and a Calorie Restricted Diet Augments Weight Loss and Decreases Risk of Type 2 Diabetes and CVD.
Stanford University
Pre-diabetes · Older Adults
Safety of Liraglutide in Pediatric Patients With Type 2 Diabetes
Novo Nordisk A/S
Diabetes · Diabetes Mellitus, Type 2
Effect of GLP-1 on Insulin-dose, Risk of Hypoglycemia and Gastric Emptying Rate in Patients With Type 1 Diabetes
Hvidovre University Hospital
Diabetes Mellitus
A Trial to Assess the Effect of Liraglutide on Blood Triglyceride (Fat) Levels After a Meal in Type 2 Diabetics
Novo Nordisk A/S
Diabetes · Diabetes Mellitus, Type 2
A Trial to Assess the Effect of Liraglutide on Gastric Emptying in Healthy Obese Volunteers
Novo Nordisk A/S
Metabolism and Nutrition Disorder · Obesity
Safety and Tolerability of NN9068 in Healthy Male Volunteers
Novo Nordisk A/S
Diabetes · Healthy
The Effect of Insulin Detemir in Combination With Liraglutide and Metformin Compared to Liraglutide and Metformin in Subjects With Type 2 Diabetes
Novo Nordisk A/S
Diabetes · Diabetes Mellitus, Type 2
Examination of the Effects of Liraglutide on the Mode of Action of Insulin Detemir
Novo Nordisk A/S
Diabetes · Diabetes Mellitus, Type 2
Comparison of Liraglutide Versus Placebo in Weight Loss Maintenance in Obese Subjects: SCALE - Maintenance
Novo Nordisk A/S
Metabolism and Nutrition Disorder · Obesity
To Investigate the Blood Concentration of Liraglutide as Well as the Effects on Glucose and Insulin After 21 Days of Daily Subcutaneous Injections of Liraglutide or Placebo
Novo Nordisk A/S
Diabetes · Healthy
A Randomised Controlled Clinical Trial in Type 2 Diabetes Comparing Semaglutide to Placebo and Liraglutide
Novo Nordisk A/S
Diabetes · Diabetes Mellitus, Type 2
The Effect of Liraglutide Compared to Sitagliptin, Both in Combination With Metformin on Glycaemic Control in Subjects With Type 2 Diabetes Mellitus
Novo Nordisk A/S
Diabetes · Diabetes Mellitus, Type 2
The Effect of Liraglutide on Endothelial Function in Subjects With Type 2 Diabetes Mellitus
Novo Nordisk A/S
Diabetes · Diabetes Mellitus, Type 2
Effect of Liraglutide or Glimepiride Added to Metformin on Blood Glucose Control in Subjects With Type 2 Diabetes
Novo Nordisk A/S
Diabetes · Diabetes Mellitus, Type 2
Effect of Liraglutide or Exenatide Added to an Ongoing Treatment on Blood Glucose Control in Subjects With Type 2 Diabetes
Novo Nordisk A/S
Diabetes · Diabetes Mellitus, Type 2
Comparison of Liraglutide Injected at Three Different Injection Sites in Healthy Volunteers
Novo Nordisk A/S
Diabetes · Healthy
The Effect of Liraglutide on Body Weight in Obese Subjects Without Diabetes
Novo Nordisk A/S
Metabolism and Nutrition Disorder · Obesity
Bioequivalence of Two Liraglutide Formulations in Healthy Volunteers
Novo Nordisk A/S
Diabetes · Healthy
Influence on the Effect of an Oral Contraceptive Drug After Administration of Liraglutide in Postmenopausal Women
Novo Nordisk A/S
Diabetes · Diabetes Mellitus, Type 2
Metabolism and Excretion of Liraglutide in Healthy Male Volunteers
Novo Nordisk A/S
Diabetes · Healthy
Effect of Liraglutide on Blood Glucose Control in Subjects With Type 2 Diabetes
Novo Nordisk A/S
Diabetes · Diabetes Mellitus, Type 2
Effect of Liraglutide in Combination With Sulfonylurea (SU) on Blood Glucose Control in Subjects With Type 2 Diabetes
Novo Nordisk A/S
Diabetes · Diabetes Mellitus, Type 2
Effect of Liraglutide on Absorption of Paracetamol in Subjects With Type 2 Diabetes
Novo Nordisk A/S
Diabetes · Diabetes Mellitus, Type 2
Effect of Liraglutide on Heart Frequency in Healthy Volunteers
Novo Nordisk A/S
Diabetes · Diabetes Mellitus, Type 2
Effect of Liraglutide on Gastrointestinal Absorption of Several Drugs and Potential Influence of Liraglutide on Intragastric pH
Novo Nordisk A/S
Diabetes · Healthy
Effect of Liraglutide on Blood Glucose Control in Subjects With Type 2 Diabetes
Novo Nordisk A/S
Diabetes · Diabetes Mellitus, Type 2
Effect of Liraglutide on Blood Glucose Control in Subjects With Type 2 Diabetes
Novo Nordisk A/S
Diabetes · Diabetes Mellitus, Type 2
To Compare the Effect of Liraglutide When Given Together With Metformin With the Effect of Metformin Given Alone and With the Effect of Glimepiride and Metformin Given Together
Novo Nordisk A/S
Diabetes · Diabetes Mellitus, Type 2
Effect of Liraglutide on Blood Glucose Control in Subjects With Type 2 Diabetes
Novo Nordisk A/S
Diabetes · Diabetes Mellitus, Type 2
Comparison of Two Liraglutide Formulations in Healthy Subjects
Novo Nordisk A/S
Diabetes · Healthy
Safety of Liraglutide in Subjects With Liver Impairment and in Subjects With Normal Liver Function
Novo Nordisk A/S
Diabetes · Diabetes Mellitus, Type 2
To Evaluate the Effect of Liraglutide Versus Glimepiride (Amaryl®) on Haemoglobin A1c
Novo Nordisk A/S
Diabetes · Diabetes Mellitus, Type 2
Safety and Tolerability of Liraglutide in Healthy Japanese Male Volunteers
Novo Nordisk A/S
Diabetes · Diabetes Mellitus, Type 2
Effect of Liraglutide Compared to Glimepiride on Appetite in Subjects With Type 2 Diabetes
Novo Nordisk A/S
Diabetes · Diabetes Mellitus, Type 2
Safety and Tolerability of Liraglutide in Subjects With Impaired Kidney Function and in Subjects With Normal Kidney Function
Novo Nordisk A/S
Diabetes · Diabetes Mellitus, Type 2
Comparison of Three Liraglutide Formulations in Healthy Volunteers
Novo Nordisk A/S
Diabetes · Healthy
Effect of Liraglutide on Blood Glucose Control in Japanese Subjects With Type 2 Diabetes
Novo Nordisk A/S
Diabetes · Diabetes Mellitus, Type 2
Effect of Liraglutide on Blood Glucose Control in Subjects With Type 2 Diabetes
Novo Nordisk A/S
Diabetes · Diabetes Mellitus, Type 2
Comparison of Two Liraglutide Formulations in Healthy Volunteers
Novo Nordisk A/S
Diabetes · Healthy
Comparison of the Effect of Liraglutide in Young Versus Elderly Healthy Volunteers
Novo Nordisk A/S
Diabetes · Healthy
Safety and Tolerability of Liraglutide in Japanese Subjects With Type 2 Diabetes
Novo Nordisk A/S
Diabetes · Diabetes Mellitus, Type 2
Safety and Tolerability of Liraglutide in Healthy Japanese Volunteers
Novo Nordisk A/S
Diabetes · Healthy
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Liraglutide in Healthy Japanese Volunteers
Novo Nordisk A/S
Diabetes · Diabetes Mellitus, Type 2
Effect of Liraglutide as add-on to Metformin Compared to Either Liraglutide or Metformin Alone, or to a Combination of Metformin and a SU (Sulphonylurea) Agent in Subjects With Type 2 Diabetes
Novo Nordisk A/S
Diabetes · Diabetes Mellitus, Type 2
Comparison of Liraglutide Inhaled Into the Lungs Compared to Liraglutide Injected Under the Skin in Healthy Male Volunteers
Novo Nordisk A/S
Diabetes · Healthy
Effect of Liraglutide on Weight and Appetite in Obese Subjects With Type 2 Diabetes
Novo Nordisk A/S
Diabetes · Diabetes Mellitus, Type 2
Effect of Liraglutide on Glucose Profiles and Gastric Emptying in Subjects With Type 2 Diabetes
Novo Nordisk A/S
Diabetes · Diabetes Mellitus, Type 2
Effect of Liraglutide on Glucagon Secretion in Subjects With Type 2 Diabetes
Novo Nordisk A/S
Diabetes · Diabetes Mellitus, Type 2
Effect of Liraglutide on the Beta-cell Responsiveness in Subjects With Type 2 Diabetes Compared to a Healthy Control Group
Novo Nordisk A/S
Diabetes · Diabetes Mellitus, Type 2
Efficacy and Safety of Metformin and Liraglutide in Obese Subjects With Type 2 Diabetes Previously Treated With an Oral Hypoglycemic Agent
Novo Nordisk A/S
Diabetes · Diabetes Mellitus, Type 2
Comparison of Liraglutide and Glimepiride on Blood Sugar Control in Subjects With Type 2 Diabetes
Novo Nordisk A/S
Diabetes · Diabetes Mellitus, Type 2
Effect of Liraglutide on Pulsatile Insulin Secretion in Subjects With Type 2 Diabetes
Novo Nordisk A/S
Diabetes · Diabetes Mellitus, Type 2
Safety and Tolerability of Liraglutide in Healthy Volunteers and Subjects With Type 2 Diabetes
Novo Nordisk A/S
Diabetes · Diabetes Mellitus, Type 2 · Healthy
Safety and Tolerability of Liraglutide in Healthy Male Volunteers
Novo Nordisk A/S
Diabetes · Healthy
R0132901
Radboud universitair medisch centrum Stichting
Diabetes
Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.
Sources: ClinicalTrials.gov, the EU Clinical Trials Information System and ISRCTN, deduplicated so a study registered in more than one registry is counted once. A study is listed when Liraglutide is named as an intervention. A registered trial is a plan, not a result — registration says nothing about whether the peptide worked.